Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

On January 9, 2026, the latest edition of Applied Artificial Intelligence for Drug Discovery was published online as a Springer Nature volume, spanning 27 chapters authored by leading international ...

Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...

SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has launched the next generation of its multi-omics and real-world ...

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...

According to MarketsandMarkets™, the Drug Discovery Technologies Market is projected to grow from about USD 30.58 billion in ...